Why the study?
Methadone can precipitate torsades de pointes, and while standard therapy includes drug discontinuation, electrolyte correction, and magnesium, some patients experience recurrent arrhythmia.
Does isoproterenol infusion resolve refractory methadone-associated torsades de pointes in a patient with alcohol withdrawal?
Does isoproterenol infusion resolve refractory methadone-associated torsades de pointes in a patient with alcohol withdrawal?
Isoproterenol infusion may be a viable therapeutic option for torsades de pointes that is refractory to first-line interventions like magnesium and lidocaine.
Answers are grounded in this paper and cite their sources.
Recurrent TdP risk persists in methadone patients during alcohol withdrawal despite standard care; case report leaves optimal adjunctive strategies open.
Methadone is known to prolong the QTc interval and may precipitate torsades de pointes (TdP), particularly at higher doses and in the presence of additional risk factors. Standard management involves discontinuation of the offending agent, correction of electrolyte imbalances, and administration of intravenous magnesium; however, some patients may continue to experience recurrent TdP. We present a case of a young female on high-dose methadone, who developed TdP in the context of acute alcohol withdrawal and clonidine-associated bradycardia. Her arrhythmia persisted despite treatment with magnesium and lidocaine but resolved following initiation of an isoproterenol infusion. This case emphasizes the importance of systematic risk assessment in patients receiving methadone and supports the use of isoproterenol as a viable therapeutic option when TdP is refractory to first-line interventions.
No takes yet. Share an insight, caveat, or question.
Wrona et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: